These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 11874177

  • 1. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N, Keller E, Landy H, Serono Study Group.
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [Abstract] [Full Text] [Related]

  • 2. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP, Shah K, Kowal K, Cutler GB, Kushner H, Ross JL.
    Horm Res Paediatr; 2011 Feb; 75(1):38-46. PubMed ID: 20733274
    [Abstract] [Full Text] [Related]

  • 3. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [Abstract] [Full Text] [Related]

  • 4. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG.
    Horm Res; 1997 Feb; 47(3):102-9. PubMed ID: 9050948
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [Abstract] [Full Text] [Related]

  • 6. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.
    Haeusler G, Frisch H, Schmitt K, Blümel P, Plöchl E, Zachmann M, Waldhör T.
    Eur J Pediatr; 1995 Jun; 154(6):437-44. PubMed ID: 7545577
    [Abstract] [Full Text] [Related]

  • 7. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P, Massarano AA, Stanhope R.
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [Abstract] [Full Text] [Related]

  • 8. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
    Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ.
    J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
    [Abstract] [Full Text] [Related]

  • 10. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E, Mazzanti L.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
    [Abstract] [Full Text] [Related]

  • 12. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
    Gawlik A, Gawlik T, Koehler B, Malecka-Tendera E, Augustyn M, Woska W.
    Endokrynol Pol; 2005 Dec; 56(2):136-44. PubMed ID: 16335681
    [Abstract] [Full Text] [Related]

  • 13. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL.
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [Abstract] [Full Text] [Related]

  • 14. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM, Cohen-Kettenis PT.
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [Abstract] [Full Text] [Related]

  • 15. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001.
    Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, Sander S, Stahnke N, Steinkamp H, Said E, Sippell W.
    Eur J Endocrinol; 2002 Nov; 147(5):625-33. PubMed ID: 12444894
    [Abstract] [Full Text] [Related]

  • 16. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K, Häusler G, Blümel P, Plöchl E, Waldhör T, Frisch H.
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of growth hormone therapy in Turner syndrome.
    Bramswig JH.
    Endocrine; 2001 Jun; 15(1):5-13. PubMed ID: 11572325
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG.
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [Abstract] [Full Text] [Related]

  • 19. Pubertal height gain in Ullrich-Turner syndrome.
    Bechtold S, Dalla Pozza R, Schmidt H, Bonfig W, Schwarz HP.
    J Pediatr Endocrinol Metab; 2006 Aug; 19(8):987-93. PubMed ID: 16995583
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K, Sas TC, Traas MA, Netea-Maier RT, den Heijer M, Hermus AR, Wit JM, van Alfen-van der Velden JA, Otten BJ, de Muinck Keizer-Schrama SM, Gotthardt M, Dejonckere PH, Zandwijken GR, Menke LA, Timmers HJ.
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.